0001415889-19-000021.txt : 20190107
0001415889-19-000021.hdr.sgml : 20190107
20190107184913
ACCESSION NUMBER: 0001415889-19-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181227
FILED AS OF DATE: 20190107
DATE AS OF CHANGE: 20190107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ross Edmund Burke Jr.
CENTRAL INDEX KEY: 0001682557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 19514318
MAIL ADDRESS:
STREET 1: C/O JDJ FAMILY OFFICE SERVICES
STREET 2: P.O. BOX 962049
CITY: BOSTON
STATE: MA
ZIP: 02196
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-01072019_030157.xml
X0306
4
2018-12-27
0001604191
AzurRx BioPharma, Inc.
AZRX
0001682557
Ross Edmund Burke Jr.
C/O JDJ FAMILY OFFICE SERVICES
PO BOX 962049
BOSTON
MA
02196
false
false
true
false
Common Stock
2018-05-02
4
P
0
20000
2.50
A
2421010
I
See Footnote
Common Stock
2018-12-27
4
P
0
42922
1.18
A
2463932
I
See Footnote
Common Stock
2018-12-27
4
P
0
23200
1.13
A
2487132
I
See Footnote
Common Stock
2018-12-28
4
P
0
29575
1.18
A
2516707
I
See Footnote
Common Stock
2018-12-31
4
P
0
23848
1.12
A
2540555
I
See Footnote
Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.
Of the aggregate number of shares purchased on May 2, 2018, CEDA Investments, LLC purchased all 20,000 shares.
Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares.
Of the aggregate number of shares purchased on December 28, 2018, EBR Ventures, LLC purchased all 29,575 shares.
Of the aggregate number of shares purchased on December 31, 2018, EBR Ventures, LLC purchased all 23,848 shares.
/s/ Edmund Burke Ross Jr. for himself and as manager of ADEC Private Equity Investment, LLC, as manager of EBR Ventures, LLC, and as manager of CEDA Investments, LLC
2019-01-07